{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:50:02Z","timestamp":1786589402461,"version":"build-2736575974"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jcf.2022.01.010","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T08:22:21Z","timestamp":1643962941000},"page":"e217-e220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Hypervitaminosis A with fulminant secondary intracranial hypertension following personalized medicine-based Elexacaftor\/Tezacaftor\/Ivacaftor initiation in a preadolescent with cystic fibrosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Benjamin L.","family":"Wisniewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn C.","family":"Aylward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine O.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin T.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace R.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2022.01.010_bib0001","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pediatrneurol.2016.08.010","article-title":"Pediatric intracranial hypertension","volume":"66","author":"Aylward","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jcf.2022.01.010_bib0002","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.1960.03020340020005","article-title":"Vitamin A intoxication as a cause of pseudotumor cerebri","volume":"173","author":"Morrice","year":"1960","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jcf.2022.01.010_bib0003","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1542\/peds.66.4.622","article-title":"Increased intracranial pressure following treatment of cystic fibrosis","volume":"66","author":"Roach","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2022.01.010_bib0004","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202101-0090LE","article-title":"Elexacaftor\/Tezacaftor\/Ivacaftor improved clinical outcomes in an N1303K-CFTR patient based on in vitro experimental evidence","author":"Huang","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2022.01.010_bib0005","article-title":"Papilledema and hypervitaminosis A after elexacaftor\/tezacaftor\/ivacaftor for cystic fibrosis","author":"Miller","year":"2021","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcf.2022.01.010_bib0006","doi-asserted-by":"crossref","DOI":"10.1177\/08830738211026798","article-title":"Case series of rapid surgical interventions in fulminant intracranial hypertension","author":"Ploof","year":"2021","journal-title":"J Child Neurol"},{"issue":"3","key":"10.1016\/j.jcf.2022.01.010_bib0007","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcf.2004.04.003","article-title":"Vitamin A levels in patients with CF are influenced by the inflammatory response","volume":"3","author":"Greer","year":"2004","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2022.01.010_bib0008","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.clnu.2015.04.010","article-title":"Vitamin A intake and serum retinol levels in children and adolescents with cystic fibrosis","volume":"35","author":"Woestenenk","year":"2016","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.jcf.2022.01.010_bib0009","article-title":"CFTR modulator therapy with Lumacaftor\/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in patients with cystic fibrosis","volume":"10","author":"Sommerburg","year":"2021","journal-title":"Antioxidants (Basel)"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:47:11Z","timestamp":1761601631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199322000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1569199322000303"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2022.01.010","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypervitaminosis A with fulminant secondary intracranial hypertension following personalized medicine-based Elexacaftor\/Tezacaftor\/Ivacaftor initiation in a preadolescent with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}